TM
PODD icon

Triatomic Management’s Insulet PODD Stock Holding History

Triatomic Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,031
Closed -$1.53M – 37
2023
Q4 		$1.53M Sell
7,031
-4,000
-36% -$686K 1.94% 12
2023
Q3 		$1.76M Buy
11,031
+1,950
+21% +$437K 1.22% 19
2023
Q2 		$2.62M Buy
9,081
+510
+6% +$155K 2.68% 12
2023
Q1 		$2.73M Sell
8,571
-2,935
-26% -$870K 1.84% 11
2022
Q4 		$3.39M Sell
11,506
-4,800
-29% -$1.32M 2.85% 11
2022
Q3 		$3.74M Sell
16,306
-4,710
-22% -$1.18M 2.15% 9
2022
Q2 		$4.58M Sell
21,016
-12,500
-37% -$2.84M 4.21% 6
2022
Q1 		$8.93M Buy
33,516
+5,800
+21% +$1.42M 7.25% 4
2021
Q4 		$7.37M Buy
+27,716
New +$8.04M 4.52% 5

Other funds holding PODD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Triatomic Management's PODD Position: Q1 2024 in Review

Triatomic Management sold out of Insulet (PODD) in Q1 2024, closing a stake of 7,031 shares — an estimated $1.53M sold.

Triatomic Management first reported a position in PODD in Q4 2021 and held it in 9 quarters. The position peaked at $8.93M in Q1 2022. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Triatomic Management reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Triatomic Management sold 7,031 Insulet shares in Q1 2024, an estimated $1.53M.
  • Triatomic Management first reported a position in Insulet in Q4 2021 and held it in 9 quarters.
  • Triatomic Management's Insulet position peaked at $8.93M in Q1 2022.
  • 563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Triatomic Management's 13F filing for Q1 2024, filed 13 May 2024.